Successful Treatment of Two Children’s with Refractory Immune Thrombocytopenic Purpura with Eltrombopag

Abstract

Immune thrombocytopenic purpura (ITP) is an acquired autoimmune disorder that affects children and adults. It is characterized by isolated thrombocytopenia with a peripheral blood platelet count < 100x109/L, and all other secondary causes must be excluded [1]. Definition of newly diagnosed ITP; within three months from diagnosis, persistent ITP; between three to 12months from diagnosis, chronic ITP; when the disease lasts for more than 12months [2].